Masunori Matsuzaki Selected Research

Masunori Matsuzaki Research Topics

Disease

60	Heart Failure 12/2017 - 01/2002
28	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 04/2003
22	Hypertension (High Blood Pressure) 02/2021 - 01/2002
17	Hypercholesterolemia 01/2012 - 05/2002
15	Acute Coronary Syndrome 08/2016 - 01/2002
14	Stroke (Strokes) 01/2020 - 11/2004
10	Coronary Disease (Coronary Heart Disease) 02/2021 - 01/2002
10	Myocardial Infarction 01/2018 - 01/2003
10	Cardiac Arrhythmias (Arrythmia) 12/2012 - 07/2002
8	Atrial Fibrillation 01/2014 - 01/2002
8	Polymorphic catecholergic ventricular tachycardia 08/2011 - 09/2005
8	Fibrosis (Cirrhosis) 08/2010 - 05/2002
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 03/2003
7	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2010 - 01/2002
6	Diabetes Mellitus 11/2013 - 01/2002
6	Atherosclerosis 01/2013 - 05/2002
6	Ventricular Remodeling 01/2012 - 03/2002
6	Abdominal Aortic Aneurysm 10/2011 - 12/2005
6	Ventricular Tachycardia 08/2011 - 06/2005
6	Infarction (Infarctions) 11/2010 - 04/2002
6	Atherosclerotic Plaque (Atheroma) 09/2010 - 07/2002
6	Cardiomyopathies (Cardiomyopathy) 01/2010 - 07/2004
5	Vascular Remodeling 10/2015 - 09/2004
5	Myocarditis (Carditis) 03/2013 - 01/2002
5	Tachycardia (Tachyarrhythmias) 01/2012 - 07/2002
5	Body Weight (Weight, Body) 12/2011 - 01/2003
4	Inflammation (Inflammations) 10/2015 - 05/2003
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 02/2021 - 07/2002
3	Dyslipidemias (Dyslipidemia) 02/2021 - 01/2011
3	Systolic Heart Failure 01/2014 - 09/2005
3	Chronic Renal Insufficiency 11/2013 - 03/2008
3	Heart Diseases (Heart Disease) 07/2010 - 12/2006
3	Obesity 03/2010 - 09/2007
3	Hypertrophy 12/2006 - 02/2003
3	Hypoxia (Hypoxemia) 08/2006 - 08/2002
3	Hypotension (Low Blood Pressure) 01/2006 - 01/2003
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2005 - 02/2003
2	Stable Angina 10/2021 - 02/2008
2	Xanthomatosis (Xanthoma) 02/2021 - 06/2016
2	Pathologic Constriction (Stenosis) 06/2017 - 10/2005
2	Sarcoidosis (Schaumann Disease) 06/2016 - 01/2015
2	Thrombosis (Thrombus) 04/2016 - 03/2012

Drug/Important Bio-Agent (IBA)

31	LipidsIBA 10/2022 - 01/2002
24	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 12/2006
18	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 12/2012 - 03/2002
13	pitavastatin (itavastatin)FDA Link 10/2022 - 11/2006
11	Angiotensin Receptor AntagonistsIBA 01/2018 - 10/2002
9	LDL CholesterolIBA 10/2022 - 01/2002
9	Simvastatin (Zocor)FDA LinkGeneric 03/2010 - 12/2002
9	CholesterolIBA 08/2008 - 01/2002
8	benidipineIBA 01/2020 - 08/2011
8	Atorvastatin (Lipitor)FDA Link 01/2013 - 12/2006
8	Eicosapentaenoic AcidIBA 01/2012 - 07/2008
8	Proteins (Proteins, Gene)FDA Link 01/2012 - 08/2002
7	oxidized low density lipoproteinIBA 02/2021 - 07/2002
7	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2018 - 04/2005
7	Carvedilol (Coreg)FDA LinkGeneric 03/2014 - 02/2004
6	HDL CholesterolIBA 01/2022 - 09/2005
6	CalciumIBA 11/2013 - 01/2003
6	Pharmaceutical PreparationsIBA 05/2009 - 05/2002
5	AntioxidantsIBA 02/2021 - 05/2002
5	ThiazidesIBA 01/2020 - 04/2012
5	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2020 - 08/2011
5	Biomarkers (Surrogate Marker)IBA 06/2016 - 09/2007
5	Angiotensin IIIBA 10/2015 - 01/2003
5	EnzymesIBA 10/2015 - 05/2003
5	Triglycerides (Triacylglycerol)IBA 01/2015 - 01/2002
5	DiureticsIBA 01/2014 - 12/2011
5	CytokinesIBA 08/2008 - 01/2003
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2005 - 10/2002
4	Probucol (Lorelco)FDA Link 02/2021 - 05/2002
4	8-Hydroxy-2'-DeoxyguanosineIBA 06/2016 - 01/2011
4	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2015 - 01/2005
4	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2015 - 05/2002
4	Rosuvastatin Calcium (Crestor)FDA Link 12/2013 - 02/2007
4	Tolvaptan FDA Link 12/2011 - 12/2011
4	JNK Mitogen-Activated Protein KinasesIBA 10/2007 - 12/2005
4	Nitric Oxide Synthase (NO Synthase)IBA 01/2005 - 05/2002
3	LDL Lipoproteins (beta Lipoproteins)IBA 02/2021 - 07/2002
3	1,4-dihydropyridine (dihydropyridine)IBA 01/2018 - 12/2013
3	Sirolimus (Rapamycin)FDA Link 04/2016 - 02/2008
3	C-Reactive ProteinIBA 01/2015 - 09/2007
3	Protein Phosphatase 1IBA 01/2012 - 06/2006
3	Amino Acids FDA Link 08/2011 - 11/2004
3	Dantrolene (Dantrium)FDA LinkGeneric 08/2011 - 05/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008 - 01/2003
3	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 06/2006 - 03/2002
3	tacrolimus binding protein 1BIBA 03/2003 - 03/2002
2	Mineralocorticoid Receptor AntagonistsIBA 12/2017 - 03/2011
2	Toll-Like Receptor 4IBA 10/2015 - 08/2015
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2015 - 10/2010
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 08/2015 - 02/2010
2	Prednisolone (Predate)FDA LinkGeneric 01/2015 - 05/2003

Therapy/Procedure

53	Therapeutics 10/2022 - 04/2002
6	Stents 06/2017 - 05/2002
5	Secondary Prevention 02/2021 - 12/2002
5	Percutaneous Coronary Intervention 11/2010 - 11/2004
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2011 - 03/2003
3	Ligation 07/2003 - 04/2002
3	Heart Transplantation (Grafting, Heart) 07/2003 - 01/2002